Meridian Bioscience Stock Price and Value Analysis

Should you buy Meridian Bioscience stock? (NasdaqGS:VIVO). Let's see how it does in our automated value investing analysis system.

VIVO Free Cash Flow Trend

Free Cash Flow trendline for VIVO
Free Cash Flow trendline for Meridian Bioscience

Based on historical returns, we believe that Meridian Bioscience can grow its free cash at a rate of about 3%. That's positive!

  • This company is solid.
  • This stock is on sale.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the VIVO Numbers

VIVO Price
(Meridian Bioscience stock price per share)
[?] VIVO Fair Price
(based on intrinsic value)
[?] VIVO Safety Price (based on a variable margin of safety) $7.03
[?] PE Ratio versus Sector 16% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Cash Yield 10.34%
[?] Free Cash Flow Jitter 42%

Is Meridian Bioscience Stock on Sale?

We believe that Meridian Bioscience may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Meridian Bioscience looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.

Should You Buy VIVO Stock?

Does Meridian Bioscience have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.